A Review on "IL-1 Receptor Antagonist Plus Pentoxifylline and Zinc for Severe Alcohol-Associated Hepatitis"

被引：0
|
作者：
Anikhindi, Shrihari [1 ]
Anikhindi, Akshay [1 ]
Kumar, Ashish [1 ]
Arora, Anil [1 ]
机构：
[1] Sir Ganga Ram Hosp, Inst Liver Gastroenterol & Pancreaticobiliary Sci, New Delhi, India
来源：
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY | 2023年 / 13卷 / 03期
关键词：
THERAPY;
D O I：
10.1016/j.jceh.2023.01.011
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：533 / 535
页数：3
相关论文
共 50 条
  • [1] IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis
    Szabo, Gyongyi
    Mitchell, Mack
    McClain, Craig J.
    Dasarathy, Srinivasan
    Barton, Bruce
    McCullough, Arthur J.
    Nagy, Laura E.
    Kroll-Desrosiers, Aimee
    Tornai, David
    Min, Hyesung Alice
    Radaeva, Svetlana
    Holbein, M. E. Blair
    Casey, Lisa
    Cuthbert, Jennifer
    HEPATOLOGY, 2022, 76 (04) : 1058 - 1068
  • [2] Letter to the editor: IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcoholic hepatitis-More questions than answers!
    Singh, Satender Pal
    Mishra, Ajay Kumar
    Jindal, Ankur
    HEPATOLOGY, 2022, 76 (05) : E112 - E113
  • [3] Letter to the editor: Combination treatment with IL-1 antagonist, pentoxifylline and zinc for severe alcoholic hepatitis: Are we there yet?
    Gupta, Shivam
    Nath, Preetam
    Anand, Anil C.
    HEPATOLOGY, 2022, 76 (05) : E110 - E111
  • [4] Randomized trial of anakinra plus zinc vs . prednisone for severe alcohol-associated hepatitis
    Gawrieh, Samer
    Dasarathy, Srinivasan
    Tu, Wanzhu
    Kamath, Patrick S.
    Chalasani, Naga P.
    McClain, Craig J.
    Bataller, Ramon
    Szabo, Gyongyi
    Tang, Qing
    Radaeva, Svetlana
    Barton, Bruce
    Nagy, Laura E.
    Shah, Vijay H.
    Sanyal, Arun J.
    Mitchell, Mack C.
    JOURNAL OF HEPATOLOGY, 2024, 80 (05) : 684 - 693
  • [5] Acute kidney injury in severe alcohol-associated hepatitis treated with anakinra plus zinc or prednisone
    Patidar, Kavish R.
    Tu, Wanzhu
    Cotter, Thomas G.
    Simonetto, Douglas A.
    Asgharpour, Amon
    Jan, Muhammad Y.
    Tang, Qing
    Yu, Yunpeng
    Li, Yang
    Taiwo, Moyinoluwa
    Thevkar Nagesh, Prashanth
    Dasarathy, Srinivasan
    Kamath, Patrick S.
    Mcclain, Craig J.
    Chalasani, Naga
    Szabo, Gyongyi
    Bataller, Ramon
    Mitchell, Mack
    Mehal, Wajahat Z.
    Nagy, Laura E.
    Shah, Vijay H.
    Gawrieh, Samer
    Sanyal, Arun J.
    HEPATOLOGY, 2024,
  • [6] IL-1 Receptor Antagonist in Combination with Pentoxifylline and Zinc for Severe Alcoholic Hepatitis: A Multicenter Randomized Double-Bind Placebo-Controlled Clinical Trial
    Szabo, Gyongyi
    Mitchell, Mack C.
    McClain, Craig J.
    Dasarathy, Srinivasan
    McCullough, Arthur J.
    Nagy, Laura
    Kroll-Desrosiers, Aimee
    Radaeva, Svetlana
    Barton, Bruce
    HEPATOLOGY, 2018, 68 (06) : 1445A - 1445A
  • [7] ANAKINRA PLUS ZINC VERSUS PREDNISONE FOR TREATMENT OF SEVERE ALCOHOL-ASSOCIATED HEPATITIS: A RANDOMIZED CONTROLLED TRIAL
    Gawrieh, Samer
    Dasarathy, Srinivasan
    Tu, Wanzhu
    Kamath, Patrick S.
    Chalasani, Naga P.
    McClain, Craig J.
    Bataller, Ramon
    Szabo, Gyongyi
    Tang, Qing
    Radaeva, Svetlana
    Barton, Bruce
    Nagy, Laura
    Shah, Vijay
    Sanyal, Arun J.
    Mitchell, Mack C.
    HEPATOLOGY, 2023, 77 (05) : E122 - E123
  • [8] Polymorphisms in IL-1β and IL-1 receptor antagonist associated with myasthenia gravis
    Huang, D
    Pirskanen, R
    Hjelmström, P
    Lefvert, AK
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 81 (1-2) : 76 - 81
  • [9] IL-8+ neutrophils drive inexorable inflammation in severe alcohol-associated hepatitis
    Guan, Yukun
    Peiffer, Brandon
    Feng, Dechun
    Parra, Maria A.
    Wang, Yang
    Fu, Yaojie
    Shah, Vijay H.
    Cameron, Andrew M.
    Sun, Zhaoli
    Gao, Bin
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (09):
  • [10] Early liver transplantation in severe alcohol-associated hepatitis
    Colmenero, Jordi
    Pose, Elisa
    Lopez-Pelayo, Hugo
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2024, 116 (12) : 661 - 663
12345